Update on the Safety and Efficacy of REP 2139 Monotherapy and Subsequent Combination Therapy with Pegylated Interferon Alpha-2A in Caucasian Patients with Chronic HBV/HDV Co-Infection
暂无分享,去创建一个
P. Schmid | M. Bazinet | M. Roggendorf | A. Krawczyk | J. Albrecht | A. Vaillant | H. Karimzadeh | V. Pântea | V. Cebotarescu | Lilia Cojuhari | P. Jimbei